Related Experiment Video
Updated: Apr 15, 2026
05:34
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
3.9K
Pulmonology: What You May Have Missed in 2025
Yusing Gu1, Sandra Ragheb1, Michael Unger2
1McMaster University, Hamilton, Ontario, Canada (Y.G., S.R.).
Annals of Internal Medicine
|April 13, 2026
Summary
Pulmonology research highlights new treatments for lung diseases. Key findings include novel antifibrotics for pulmonary fibrosis and insights into corticosteroid use for pneumonia.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Research
Background:
- Pulmonology research continuously evolves, necessitating a review of recent advancements.
- Identifying practice-changing evidence in respiratory conditions is crucial for clinical updates.
Purpose of the Study:
- To review landmark pulmonology publications from 2025.
- To highlight novel treatments and evidence in interstitial lung disease, pneumonia, COPD, asthma, and bronchiectasis.
Main Methods:
- Screened over 900 studies published in 2025.
- Selected 8 key articles representing significant advancements in respiratory medicine.
Main Results:
- Novel antifibrotic agent for pulmonary fibrosis and methotrexate for sarcoidosis.
- Corticosteroid efficacy in community-acquired pneumonia and mepolizumab for eosinophilic COPD.
- Comparative trial of biologics in asthma/CRSwNP and new agent for bronchiectasis exacerbations.
Conclusions:
- Recent pulmonology research offers significant therapeutic advancements.
- These findings have the potential to change clinical practice across various respiratory conditions.
More Related Videos
Related Concept Videos
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K
01:29Pulmonary Embolism I: Introduction
1.3K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.3K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
685
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
685